Skip to main content
. 2013 Nov;87(22):12260–12269. doi: 10.1128/JVI.01948-13

Table 2.

Oligonucleotides used in this work

Target Primer (forward/reverse, 5′–3′)a
Protein expression
    lamB CTAGCTAGCCATGGTTATGCGCGT/CCCAAGCTTTTACCACCAGGCTTCG
    ail GGGATCCAGTATTTCTATTGGATATGC/GGTCGACTTAACCCACTTTCACATCATCG
    ompF GGGATCCTACGGTAAAGTTGACGC/GGTCGACTTAGGACTGAACATAACCCAG
    ompA GGGATCCGGTTTAGTATGGCGTGC/GGTCGACTTAAGCCTGTGGCTGAGTC
    gp17 CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAGTTTCGAACTAAG
    gp17(1–469) CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAATCGACCATCTTG
    gp17(1–119) CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAAGTATCCGCAG
    gp17(470–569) CTAGCTAGCGGACTACTCACTACCG/CCCAAGCTTTCAGTTTCGAACTAAG
Construction of mutants
    Kanamycin resistance cassette
        waaA ATGAATAACCACGGCTCAATGTGGTGCTCCGCCCTCCTAGGTGTAGGCTGGAGCTGCTTC/TTAGTGGCTCCGTTGTGGCAGATAAGGCTCCAACAAATGTCATATGAATATCCTCCTTA
        lamB ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGGTGTAGGCTGGAGCTGCTTC/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCACATATGAATATCCTCCTTA
        ail ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAAGTGTAGGCTGGAGCTGCTTC/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTCATATGAATATCCTCCTTA
        ompF ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGGTGTAGGCTGGAGCTGCTTC/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGCATATGAATATCCTCCTTA
        ompA TTGCCTATTTGGATGATAATGAGGCGTAAAATGAAAAAGAGTGTAGGCTGGAGCTGCTTC/TTAAGCCTGTGGCTGAGTCACAACTTCTTTGTAGCCTTTCCATATGAATATCCTCCTTA
    Chloromycetin resistance cassette
        lamB ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGAGATTGCAGCATTACACGTC/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCATGTAACGCACTGAGAAGC
        ail ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAAAGATTGCAGCATTACACGTC/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTTGTAACGCACTGAGAAGC
        ompF ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGAGATTGCAGCATTACACGTC/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGTGTAACGCACTGAGAAGC
        ompA TTGCCTATTTGGATGATAATGAGGCGTAAAATGAAAAAGAAGATTGCAGCATTACACGTC/TTAAGCCTGTGGCTGAGTCACAACTTCTTTGTAGCCTTTCTGTAACGCACTGAGAAGC
    Gentamicin resistance cassette
        lamB ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGTTAGGTGGCGGTACTTGGG/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCACGTCAGGTGGCACTTTTCG
        ail ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAATTAGGTGGCGGTACTTGGG/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTCGTCAGGTGGCACTTTTCG
        ompF ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGTTAGGTGGCGGTACTTGGG/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGCGTCAGGTGGCACTTTTCG
Verification of the mutants
    waaA CTGCGGCAGGTTACAAGAAG/ATGTGTGCTAGTCGCAATCC
    lamB TACTCAAGAAGGTTACTCG/GTTGGCATAAGTTGCGAAG
    ail ACTGGGGAGTGATAGGTTC/TTACTTCTACTCTCTGATTG
    ompF CGGCAACGCAACCCGTCTG/CTTCAGAACGGTCATTTTTG
    ompA GGGTGGTTTAGTATGGCGTG/TCCTGACCAAAGCGGTAAG
Complementation of mutants
    lamB CGCGGATCCGCCCAGAACATC/CCCAAGCTTGTACCAGACAGAGTG
    ompF CGCGGATCCCCGTTGCGGCGATGGATG/CCCAAGCTTTTTTCAAACATGTCAGAG
    ail CGCGGATCCCCATTGAGCGTGTGAAAC/CCCAAGCTTCAACTTTACCGTCTCAAC
    ompA CGCGGATCCTACAGTGTTGTTCTGGG/CCCAAGCTTTACTGAACCCCC
    waaA CGCGGATCCGTGCAAAAGCCGTAGTC/CCCAAGCTTCGATTTTAAGCTCTGGG
a

Underlining indicates endonuclease restriction sites.